Dr. Bob Walker will provide updates on this program shortly ... And with this progress, we are already seeing that ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

The US Food and Drug Administration (FDA) has removed the clinical hold on the Investigational New Drug (IND) application for ...

Novavax NVAX is scheduled to report third-quarter 2024 earnings on Nov. 12, before the opening bell. In the last reported ...

available at www.sec.gov and www.novavax.com, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this ...

China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...

Novavax yesterday announced that the US Food and Drug Administration (FDA ... said today in its weekly avian flu update.

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...

The SLOOS report will provide updates on the conditions ... Shift4 Payments Inc (FOUR), Mosaic (MOS), Roivant Sciences (ROIV), Repligen (RGEN), Rocket Lab USA (RKLB), Legend Bio (LEGN), Marathon ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

Drug maker Novavax Inc. (NVAX), while reporting narrower net loss in its third quarter, on Tuesday trimmed its fiscal 2024 forecast ...

J.P. Morgan analyst Eric Joseph maintained a Sell rating on Novavax (NVAX – Research Report) yesterday and set a price target of $9.00. Eric Joseph has given his Sell rating due to a combination of ...